Multi-million pound UK-wide platform into cancer immunotherapy launches

The October issue of PiP has now been published and is available to read online.

BD has announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies.

For the third year in a row the challenges facing the UK’s HealthTech industry have continued to grow, the latest sector-wide study has revealed. It shows that whilst the sector continues to provide critical life-enhancing technologies and...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukaemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of these gene fusions...